This study is currently not recruiting participants.

A Phase II Double-Blind Randomized Placebo-Controlled Pilot Study of azficel-T for the Treatment of Restrictive Burn Scars

Not Recruiting
18 years - 100 years
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to see if an investigational new treatment not approved by the Food and Drug Administration (FDA) will help improve the range of motion in joints that are restricted by a burn scar.

Detailed description of study

The purpose of this study is to see if an investigational new treatment not approved by the Food and Drug Administration (FDA) will help improve the range of motion in joints that are restricted by a burn scar.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
  • Age: 18 years - 100 years
  • Gender: All
Updated on 25 Apr 2014. Study ID: 1403906305

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team